These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24670789)

  • 1. Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy.
    Torella D; Ellison GM; Torella M; Vicinanza C; Aquila I; Iaconetti C; Scalise M; Marino F; Henning BJ; Lewis FC; Gareri C; Lascar N; Cuda G; Salvatore T; Nappi G; Indolfi C; Torella R; Cozzolino D; Sasso FC
    J Am Heart Assoc; 2014 Mar; 3(2):e000434. PubMed ID: 24670789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase II/sodium-proton exchanger 1 metabolon complex in cardiomyopathy of ob
    Jaquenod De Giusti C; Blanco PG; Lamas PA; Carrizo Velasquez F; Lofeudo JM; Portiansky EL; Alvarez BV
    J Mol Cell Cardiol; 2019 Nov; 136():53-63. PubMed ID: 31518570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibition prevents and reverts cardiomyocyte hypertrophy.
    Alvarez BV; Johnson DE; Sowah D; Soliman D; Light PE; Xia Y; Karmazyn M; Casey JR
    J Physiol; 2007 Feb; 579(Pt 1):127-45. PubMed ID: 17124262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase II promotes cardiomyocyte hypertrophy.
    Brown BF; Quon A; Dyck JR; Casey JR
    Can J Physiol Pharmacol; 2012 Dec; 90(12):1599-610. PubMed ID: 23210439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
    Louhelainen M; Vahtola E; Forsten H; Merasto S; Kytö V; Finckenberg P; Leskinen H; Kaheinen P; Tikkanen I; Levijoki J; Mervaala E
    J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
    Wu W; Liu X; Han L
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice.
    Chen Y; Du J; Zhao YT; Zhang L; Lv G; Zhuang S; Qin G; Zhao TC
    Cardiovasc Diabetol; 2015 Aug; 14():99. PubMed ID: 26245924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of carbonic anhydrase prevents the Na(+)/H(+) exchanger 1-dependent slow force response to rat myocardial stretch.
    Vargas LA; Díaz RG; Swenson ER; Pérez NG; Álvarez BV
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H228-37. PubMed ID: 23709596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of JNK and p38 MAPK-mediated inflammation and apoptosis by ivabradine improves cardiac function in streptozotocin-induced diabetic cardiomyopathy.
    Zuo G; Ren X; Qian X; Ye P; Luo J; Gao X; Zhang J; Chen S
    J Cell Physiol; 2019 Feb; 234(2):1925-1936. PubMed ID: 30067872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
    Streicher JM; Ren S; Herschman H; Wang Y
    Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic Cardiomyopathy.
    Ye Y; Birnbaum Y; Widen SG; Zhang Z; Zhu S; Bajaj M; Chen H
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):835-848. PubMed ID: 32767170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
    Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
    Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
    Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
    Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High glucose induces Drp1-mediated mitochondrial fission via the Orai1 calcium channel to participate in diabetic cardiomyocyte hypertrophy.
    Wu QR; Zheng DL; Liu PM; Yang H; Li LA; Kuang SJ; Lai YY; Rao F; Xue YM; Lin JJ; Liu SX; Chen CB; Deng CY
    Cell Death Dis; 2021 Feb; 12(2):216. PubMed ID: 33637715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the
    Sun Y; Wang Q; Fang Y; Wu C; Lu G; Chen Z
    Dis Model Mech; 2017 Oct; 10(10):1217-1227. PubMed ID: 28801532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with crocin improves cardiac dysfunction by normalizing autophagy and inhibiting apoptosis in STZ-induced diabetic cardiomyopathy.
    Feidantsis K; Mellidis K; Galatou E; Sinakos Z; Lazou A
    Nutr Metab Cardiovasc Dis; 2018 Sep; 28(9):952-961. PubMed ID: 30017436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model.
    Wu B; Huang XY; Li L; Fan XH; Li PC; Huang CQ; Xiao J; Gui R; Wang S
    J Cell Mol Med; 2019 Nov; 23(11):7651-7663. PubMed ID: 31565849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High glucose facilitated endothelial heparanase transfer to the cardiomyocyte modifies its cell death signature.
    Wang F; Jia J; Lal N; Zhang D; Chiu AP; Wan A; Vlodavsky I; Hussein B; Rodrigues B
    Cardiovasc Res; 2016 Dec; 112(3):656-668. PubMed ID: 27979811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK in Cardiovascular Diseases.
    Daskalopoulos EP; Dufeys C; Beauloye C; Bertrand L; Horman S
    Exp Suppl; 2016; 107():179-201. PubMed ID: 27812981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.